US20200245898A1 - Single-use Microfluidic Cartridge for Detection of Target Chemical Presence in Human Breath - Google Patents
Single-use Microfluidic Cartridge for Detection of Target Chemical Presence in Human Breath Download PDFInfo
- Publication number
- US20200245898A1 US20200245898A1 US16/425,938 US201916425938A US2020245898A1 US 20200245898 A1 US20200245898 A1 US 20200245898A1 US 201916425938 A US201916425938 A US 201916425938A US 2020245898 A1 US2020245898 A1 US 2020245898A1
- Authority
- US
- United States
- Prior art keywords
- cartridge
- target chemical
- reaction chamber
- channel
- breath
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000126 substance Substances 0.000 title claims abstract description 84
- 238000001514 detection method Methods 0.000 title claims description 7
- 238000000034 method Methods 0.000 claims abstract description 34
- 238000004458 analytical method Methods 0.000 claims abstract description 24
- 230000008569 process Effects 0.000 claims abstract description 17
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 14
- 238000004321 preservation Methods 0.000 claims abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims description 76
- 239000012530 fluid Substances 0.000 claims description 15
- 239000013641 positive control Substances 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 12
- 239000000443 aerosol Substances 0.000 claims description 11
- 239000000758 substrate Substances 0.000 claims description 11
- 238000002967 competitive immunoassay Methods 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- 238000003556 assay Methods 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 239000012149 elution buffer Substances 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 2
- 239000000523 sample Substances 0.000 description 50
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 24
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 24
- 229960004242 dronabinol Drugs 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 238000012360 testing method Methods 0.000 description 9
- 238000010828 elution Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 230000004044 response Effects 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 5
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 4
- 230000002745 absorbent Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000011534 wash buffer Substances 0.000 description 3
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000023077 detection of light stimulus Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/082—Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/097—Devices for facilitating collection of breath or for directing breath into or through measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4845—Toxicology, e.g. by detection of alcohol, drug or toxic products
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N1/22—Devices for withdrawing samples in the gaseous state
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/497—Physical analysis of biological material of gaseous biological material, e.g. breath
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B2010/0083—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements for taking gas samples
- A61B2010/0087—Breath samples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0431—Portable apparatus, e.g. comprising a handle or case
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0443—Modular apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0487—Special user inputs or interfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0247—Pressure sensors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N1/22—Devices for withdrawing samples in the gaseous state
- G01N1/2202—Devices for withdrawing samples in the gaseous state involving separation of sample components during sampling
- G01N1/2208—Devices for withdrawing samples in the gaseous state involving separation of sample components during sampling with impactors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N1/22—Devices for withdrawing samples in the gaseous state
- G01N1/2202—Devices for withdrawing samples in the gaseous state involving separation of sample components during sampling
- G01N2001/222—Other features
- G01N2001/2223—Other features aerosol sampling devices
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N1/22—Devices for withdrawing samples in the gaseous state
- G01N2001/2244—Exhaled gas, e.g. alcohol detecting
Definitions
- the present disclosure relates to a cartridge within a portable and handheld breath collection and analysis device, for analysis of a chemical present in a human body.
- the present disclosure is directed to a single-use microfluidic cartridge for detection of a target chemical present in human breath via a breath collection and analysis device, the cartridge comprising: a breath collection module configured to collect a desired volume of air from the human subject, and extract a target chemical from the collected air; an evidence sample storage chamber configured to preserve a sample of the extracted target chemical from the collected air for later analysis; and a multi-channel reaction chamber configured to process a competitive immunoassay to generate a signal representing a concentration amount of the target chemical present in the collected air from the human subject.
- the present disclosure is directed to a method for detection of a target chemical present in human breath via a single-use microfluidic cartridge, the method comprising: receiving a desired volume of air from a human subject in a breath collection module of the single-use microfluidic cartridge; processing the received air in the breath collection module to solubilize and extract the target chemical present in the received air from a surface upon which particles in the breath are collected and concentrated; combining the extracted target chemical with an antibody; saving a portion of the extracted target chemical for evidence preservation; reacting a remainder portion of the extracted target chemical in a multi-channel reaction chamber with one or more chemical reagents; washing the reacted chemicals in the multi-channel reaction chamber with a wash solution; introducing a substrate to the washed chemicals in the multi-channel reaction chamber, the substrate configured to emit a low level light from the single-use microfluidic cartridge, communicating with a detector device to determine a concentration level of the target chemical from the emitted low level light.
- FIG. 1 illustrates an exemplary front view of a portable breath collection and analysis device.
- FIG. 2 illustrates an exemplary back view of a portable breath collection and analysis device.
- FIG. 3 illustrates exemplary air flow from a mouthpiece via a pump system.
- FIG. 4 illustrates a simplified top view of elution and air flow in a cartridge.
- FIG. 5 depicts an exemplary front view of a single-use cartridge.
- FIG. 6 depicts an exemplary back view of a single-use cartridge.
- FIG. 7 is a simplified schematic of a single-use cartridge.
- FIG. 8 illustrates exemplary reaction processes that occur on the single-use cartridge.
- FIG. 9 is an exemplary flow chart of a process conducted within reaction chamber of the single-use cartridge.
- FIG. 10 is an exemplary flow of a process conducted on the single-use cartridge.
- a hyphenated term (e.g., βon-demandβ) may be occasionally interchangeably used with its non-hyphenated version (e.g., βon demandβ)
- a capitalized entry e.g., βDeviceβ
- its non-capitalized version e.g., βdeviceβ
- a plural term may be indicated with or without an apostrophe (e.g., PE's or PEs)
- an italicized term e.g., βN+1β may be interchangeably used with its non-italicized version (e.g., βN+1β).
- Such occasional interchangeable uses shall not be considered inconsistent with each other.
- the present disclosure pertains to methods, systems, and apparatus for capturing human breath at a point of care, extracting certain chemical(s) from the captured breath, and measuring a concentration of the extracted chemicals.
- an amount of tetrahydrocannabinol (THC) level from a breath sample is determined by practicing embodiments of the present disclosure. While THC is discussed herein for simplicity, similar methods can be utilized to extract and measure a concentration of other chemicals in human breath as well, such as ethanol, other controlled substances, or airborne indicators of various disease states.
- Embodiments of the present disclosure describe a proprietary microfluidic cartridge that is disposable, and used within a portable breath collection and analysis device.
- the cartridge is located within a portable handheld device and provides for mechanisms to capture and accurately measure an amount of a target chemical that is present in a person's breath.
- the target chemical is THC.
- THC When THC is present in human breath, the bulk of it is contained within aerosol droplets.
- the present disclosure relates to mechanisms for capturing those aerosol droplets from human breath, such that a sufficient amount of THC can be captured from a human breath sample to accurately analyze.
- the THC is extracted from a physical surface of an impaction plate where it is collected and concentrated.
- the extracted THC is subjected to further analysis, such as to measure a concentration level.
- the disposable cartridge also allows for processing on-board calibrators, positive controls, and negative controls.
- the disposable cartridge may contain a cryptographic computing chip with an RFID tag to attach personal information about the human subject's sample contained and analyzed within the cartridge.
- FIG. 1 depicts an exemplary front view of a portable breath collection and analysis device 100 (also sometimes referred to herein as simply device 100 ).
- breath collection and analysis device 100 is a handheld device that can be used at a point of care in any indoor or outdoor location.
- Device 100 may be utilized in conjunction with a base station (not shown), to accurately determine an amount of a target chemical that is present in a human subject's breath at a given time.
- display 110 that may or may not be a touchscreen. From this display 110 , an administrator utilizing device 100 to test a subject's breath can view information and results about the breath collection and sampling. As would be understood by persons of ordinary skill in the art, any information can be displayed on the display 110 for the administrator of device 100 and/or a subject whose breath is being tested.
- FIG. 1 also depicts a light array 105 .
- Light array 105 may be one or more lights of any kind (such as LED lights), to quickly indicate a status of breath collecting, analysis, or other items. As would be understood by persons of ordinary skill in the art, light array 105 may be located at other places on device 100 , and not solely in the location depicted in FIG. 1 .
- Device 100 also contains a mouthpiece 115 , which may be a disposable tube that is placed into a subject's mouth while the subject breathes air into device 100 .
- mouthpiece 115 may be constructed of PVC (polyvinyl chloride) or similar material. Mouthpiece 115 may be further connected to device 100 . In this way, mouthpiece 115 may be a removable and disposable component of device 100 .
- FIG. 2 depicts an exemplary back view of breath collection and analysis device 100 .
- a power button 125 is depicted in the exemplary figure to turn device 100 on and off. In various embodiments, power button 125 may be located at other places on device 100 , rather than solely in the location depicted in exemplary FIG. 2 .
- FIG. 3 depicts a simplified breath collection mechanism for device 100 .
- a mouthpiece 115 is placed into a subject's mouth.
- a breath collection module 305 captures air with aerosol droplets potentially containing the target chemical from the subject's breath, until a predetermined volume of air has been captured.
- a pump 310 that is triggered by a pressure sensor 315 , may aid in drawing the subject's breath from mouthpiece 115 through breath collection module 305 .
- pressure sensor 315 detects that a human subject is blowing air through mouthpiece 115 , it activates (suction) pump 310 to increase the flow rate of air into it and facilitate breath capture.
- pressure sensor 315 detects a positive pressure at mouthpiece 115 and triggers the pump 310 to turn on. When the subject stops breathing, then pump 310 stops as well. Pump 310 may be connected via a TTL connection to other hardware components within device 100 .
- 18 liters of breath is desired to be captured within 2 minutes. For a typical human subject, this is approximately 3-10 breaths.
- device 100 tracks an amount of volume of air collected with each breath of the subject, until the full desired volume is collected. Further, with each breath, pump 310 is activated and then turns off when the breath stops, as detected by pressure sensor 315 . That is, if a human subject blows into mouthpiece 115 four times, pump 310 turns on and off with each breath (four times total), within the allotted time (2 minutes in this exemplary embodiment).
- device 100 can track an amount of volume of air collected via a timer.
- Pump 310 dictates a flow rate of air passing through breath collection module 305 .
- a flow rate of air passing through breath collection module 305 is fixed, regardless of how fast or slow a subject blows through mouthpiece 115 . Since the flow rate is dictated by pump 310 , and is a known value, an amount of time needed to collect a fixed volume of air (such as 18 liters) can be determined.
- Device 100 may count down the time for each breath, until the requisite amount of time has elapsed and the desired volume of air is captured. This may help determine depth of sample volume from the subject's respiratory tract to minimize a potential for spoofing the system.
- breath collection module 305 may also filter out saliva from the subject's breath.
- Breath collection module contains a plurality of internal components that are discussed in greater detail in co-pending U.S. patent application Ser. No. NNN filed on DDD.
- elution is used to extract the target chemical from the aerosol droplets in the captured breath.
- elution is the process of extracting one material from another by washing with a solvent.
- the captured aerosol droplets are contacted with a fluid to solubilize the target chemical from the aerosol droplets into a solution.
- a fluid to solubilize the target chemical from the aerosol droplets into a solution.
- An elution buffer serves to remove the target chemical from an impactor surface in the breath collection module 305 , and is also utilized as a solvent for a reagent in an immunoassay utilized by a cartridge within device 100 to analyze the concentration of the target chemical present in the captured sample.
- the elution buffer is compatible to an antibody in the immunoassay utilized downstream in device 100 , but also has properties that extract the target chemical from the impactor surface.
- FIG. 4 depicts a top down view of elution and air flow. After air passes through an impactor surface 405 of breath collection module 305 and the desired volume of air is captured, the elution fluid passes through the impactor surface 405 to capture the target chemical.
- aerosol droplets containing the target chemical are captured from an air flow by impactor surface 405 in breath collection module 305 , and the remainder of the air is deflected outwards.
- a restrictor may be used in the breath collection module 305 to divert some air (such as up to 5% of air) to a separate path, such as a path to a blood alcohol concentration sensor, the pressure sensor 315 , and/or any other sensors. While air flow is being captured, no liquid flow is present.
- the air ports may be blocked off via one or more valves, and elution fluid is passed through impactor surface 405 to extract the target chemical from the captured aerosol droplets.
- the elution liquid with the extracted target chemical is then sent downstream to a reaction chamber 410 within a cartridge inside device 100 , for analysis of target chemical concentration.
- FIG. 5 depicts an exemplary front view of a single-use (disposable) cartridge 500 that is utilized within device 100 for analysis of the target chemical.
- Cartridge 500 is connected to mouthpiece 115 , and breath collection module 305 , which may also be single-use components for device 100 .
- Cartridge 500 contains electronic and chemical components for extraction and analysis of the target chemical in the captured breath sample from the subject.
- FIG. 6 depicts an exemplary back view of single-use cartridge 500 .
- FIG. 7 is a simplified schematic of a cartridge 500 that is used within device 100 .
- breath is captured by breath collection module 305 , facilitated by pump 310 .
- the excess air (after the aerosol droplets have been captured), is released through a vent in the handheld device 100 .
- an elution fluid with antibody-enzyme conjugate is passed through breath collection module 305 , as discussed above with reference to FIG. 4 .
- the solubilized target chemical plus the added antibodies are then directed to a reaction chamber 710 and evidence sample storage 705 .
- the reaction chamber 710 is pre-coated with THC-BSA (Bovine Serum Albumin) conjugate.
- THC-BSA Bovine Serum Albumin conjugate
- a process occurs whereby, the sample incubates for a period of time to allow the antibody to competitively bind to target analyte in sample as well as the antigen coated on the surface.
- the reaction chamber 710 is then washed to remove any unbound species.
- a substrate is introduced, which generates a signal proportional to the number of antibody-enzyme molecules bound to the reaction surface.
- the reaction chamber 710 contains three separate and parallel reaction channels: a calibrator channel 805 , a sample channel 810 , and a positive control channel 815 .
- the assay is performed within reaction chamber 710 such that three separate signals are generatedβone for each reaction channel.
- the final determination of concentration of target chemical is based on the ratio of the sample signal to the calibrator signal.
- the fluid entering reaction chamber 710 has antibody mixed with the target chemical (THC in this example). This fluid enters the sample channel 810 .
- the fluid In the calibrator channel, the fluid is just the antibody, which may or may not be mixed with a solution.
- In the positive control channel 815 there is a separate reservoir that contains a known amount of the target chemical. The positive control channel 815 and calibrator channel 805 are utilized to ensure that the workflow of the assay in the sample channel 810 processed correctly, and that the reagents of cartridge 500 are functioning properly.
- Calibrator channel 805 allows for the correction of any small deviations in the response of the chemical reagents present in cartridge 500 . It can act to compensate for small changes in environmental conditions as well (such as temperature), and/or small changes in the optical train from system to system or cartridge to cartridge. No target chemical is present in calibrator channel 805 , and thus it functions as a negative control.
- reaction chamber 710 provides a competitive immunoassay. That is, the generated signal decreases with an increase in concentration of the target chemical, as depicted in graph 820 . For example, higher signal values indicate a lower concentration of THC, and vice versa.
- calibrator channel 805 since calibrator channel 805 has no target chemical, it should have a maximum signal value. This provides a baseline for normalization. While there may be some differences in reagent activity from cartridge to the next, calibrator channel 805 provides for the normalization of a signal within each cartridge, since the same reagent is used in all three reaction channels. Thus, the relative response of the reagent in all three channel is harmonized, and a target chemical concentration can be determined based on a relative response between the three reaction channels, rather than an absolute magnitude of a signal generated in any one particular reaction chamber. Thus, calibrator channel 805 creates a relative signal to a maximum signal possible.
- Positive control chamber 815 contains the target chemical (THC), completely isolated from the sample. It is placed in a separate reservoir in the reaction chamber 710 . Since the concentration of the target chemical in the positive control sample is known, the expected response of the reagent and the expected signal generated by positive control chamber 815 is known. By checking the response generated from positive control chamber 815 against the expected response, it can be objectively determined if the sample processed correctly through the reaction chamber 710 . In this way, device 100 can provide a mechanism to verify its own accuracy of reaction chamber 710 .
- THC target chemical
- reaction area 830 of reaction chamber 710 undergoes a multi-step process. Fluid is introduced into reaction area 830 via all three reaction channels 805 , 810 , and 815 . Subsequently, the antibody is introduced into reaction area 830 . It competes with any THC present, whether that THC was introduced from the sample chamber 810 or the positive control chamber 815 . It then binds to an antigen that is on reaction surface 825 and forms a THC-BSA conjugate.
- reaction area 830 is washed by sending a wash buffer solution through reaction area 830 .
- the wash buffer solution clears away any unbound species from reaction area 830 .
- the wash buffer solution may be introduced anywhere from 1-10 times.
- a substrate is introduced into reaction area 830 .
- the substrate may be a small molecule such as luminol.
- Luminol in the presence of an oxidizing agent and an enzyme such as Horseradish Peroxidase (HRP) emits light.
- HRP Horseradish Peroxidase
- a catalyst for the reaction may be used within reaction area 830 .
- the catalyst is horseradish peroxidate enzyme (HRP). This enzyme catalyzes luminol and produces light. HRP enzyme has a high turnover rate and serves as an effective catalyst for reactions in reaction area 830 .
- the amount of light emitted from reaction chamber 710 is in the order of 0.1-10 pW.
- a detector 715 located in a base station is used to detect the light emitted from reaction chamber 710 .
- detector 715 is a silicon photomultiplier for low light detection.
- the base station processes the received light signal and determines a concentration of THC that was present in the sample collected from the human subject's breath.
- the detector 715 may be placed in physical proximity to reaction chamber 715 , when cartridge 500 is removed from device 100 .
- cartridge 500 may have optical fibers with liquid light guides to assist with detection of light being emitted from reaction chamber 715 . This allows for positional flexibility as to where the detector is placed relative to cartridge 500 .
- cartridge 500 may also have a cryptographic computing chip to store information on the single-use cartridge itself.
- the cryptographic computing chip ensures that cartridge 500 can only be utilized with an approved device 100 , base station, and/or detector 715 .
- cryptographic computing chip may contain a read/write RFID tag to store information about the human subject whose sample is contained within cartridge 500 .
- information regarding the human subject such as any one or more of a unique identifier number, name, age, address, phone number, etc. may be stored on the RFID tag of the cryptographic computing chip on cartridge 500 .
- objective information such as any one or more of date, time, location, identifier for person administering the test via device 100 , etc.
- device information and measurement(s) may also be stored in the cryptographic computing chip.
- device information and measurement(s) may also be stored on the cryptographic computing chip such as any one or more of breath collection workflow (e.g., breath volume collected, flow rate, number/duration of breaths collected by device 100 ), assay workflow (e.g., reaction light levels of optical measurements from the reactions), system serial numbers, calibration dates, quantities of the one or more target chemicals, such as a THC level and/or BAC (Blood Alcohol Content) level.
- breath collection workflow e.g., breath volume collected, flow rate, number/duration of breaths collected by device 100
- assay workflow e.g., reaction light levels of optical measurements from the reactions
- system serial numbers e.g., reaction light levels of optical measurements from the reactions
- calibration dates e.g., quantities of the one or more target chemicals, such as a THC level and/or BAC (Blood Alcohol Content) level.
- mechanisms other than an RFID tag may also be used to store information on the cryptographic computing chip. Further, any type of information other than that enumerated here may be stored on the chip.
- FIG. 7 also depicts an evidence sample storage 705 chamber in cartridge 500 . Because a sample is usually collected at a point of use away from a testing laboratory, the result from reaction chamber 710 is written into the cartridge, such as on the cryptographic computing chip of cartridge 500 . However, it is desirable to be able to corroborate this result in a laboratory at a later time using a reference method such as LC-MS.
- Evidence sample storage 705 contains a filter with an absorbent material that absorbs the received sample.
- the absorbent material containing the sample can be removed from cartridge 500 , the contents extracted from the absorbent material into a solvent such as methanol, and then fluid can be processed using known methods such as mass spectrometry. In this way, the absorbent material retains an amount of the original sample before it is processed by reaction chamber 710 of cartridge 500 , and preserves that sample for later testing.
- THC is prone to oxidation and degradation of its molecules over time.
- a key driver of degradation is light exposure.
- evidence sample storage 705 shields the sample within a compartment of cartridge 500 such that the sample is opaque on all sides.
- FIG. 9 depicts an exemplary flow chart of a process conducted within the reaction chamber of cartridge 700 . It would be understood that there may be fewer or additional steps present than those depicted in the exemplary figure, according to various embodiments of the present disclosure.
- a sample is received by the reaction chamber for analysis of a target chemical.
- the sample is received from a breath collection module.
- the received sample is reacted with one or more chemical reagents, as discussed herein.
- the reacted chemicals are then washed with a wash solution in step 915 .
- a substrate is introduced to the washed and reacted chemicals in step 920 .
- a result of the reaction process is generated and saved on a cryptographic computing chip of the cartridge, in step 925 .
- FIG. 10 depicts an exemplary flow of a process conducted by cartridge 500 for analysis of a human breath sample received from a human subject.
- an air sample is received from a human subject in a breath collection module of cartridge 500 .
- the received air sample is processed in the breath collection module to solubilize and extract a target chemical in step 1010 .
- the extracted target chemical is combined with an antibody substance in step 1015 .
- a portion of the extracted target chemical is saved for evidence preservation in an evidence sample storage compartment of the cartridge.
- a remainder portion of the extracted target chemical is reacted in a reaction chamber with one or more chemical reagents in step 1025 .
- the reacted chemicals are then washed in the reaction chamber with a wash solution in step 1030 .
- a substrate is introduced to the washed chemicals in the reaction chamber in step 1035 .
- a result of the process is generated and saved on a cryptographic computing chip of the cartridge, in step 1040 .
- a low level light may be generated by the reaction chamber of the cartridge, for detection by a detector device that is separate and apart from the cartridge.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Physiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Anesthesiology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
Description
- The present application claims the priority benefit of U.S. Provisional Patent Application No. 62/799,675 filed on Jan. 31, 2019, which is incorporated by reference herein in its entirety.
- The present disclosure relates to a cartridge within a portable and handheld breath collection and analysis device, for analysis of a chemical present in a human body.
- Existing portable systems exist for measuring a concentration of ethanol present in a person's body, via their breath. However, such portable systems do not presently exist for measuring other substances accurately in a human body. The present disclosure is directed to a replaceable cartridge that can be utilized in a portable system for collecting and determining a measurement of such other substances in a human body via a breath collection and analysis device.
- This summary is provided to introduce a selection of concepts in a simplified form that are further described in the Detailed Description below. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter.
- In one embodiment, the present disclosure is directed to a single-use microfluidic cartridge for detection of a target chemical present in human breath via a breath collection and analysis device, the cartridge comprising: a breath collection module configured to collect a desired volume of air from the human subject, and extract a target chemical from the collected air; an evidence sample storage chamber configured to preserve a sample of the extracted target chemical from the collected air for later analysis; and a multi-channel reaction chamber configured to process a competitive immunoassay to generate a signal representing a concentration amount of the target chemical present in the collected air from the human subject.
- In another embodiment, the present disclosure is directed to a method for detection of a target chemical present in human breath via a single-use microfluidic cartridge, the method comprising: receiving a desired volume of air from a human subject in a breath collection module of the single-use microfluidic cartridge; processing the received air in the breath collection module to solubilize and extract the target chemical present in the received air from a surface upon which particles in the breath are collected and concentrated; combining the extracted target chemical with an antibody; saving a portion of the extracted target chemical for evidence preservation; reacting a remainder portion of the extracted target chemical in a multi-channel reaction chamber with one or more chemical reagents; washing the reacted chemicals in the multi-channel reaction chamber with a wash solution; introducing a substrate to the washed chemicals in the multi-channel reaction chamber, the substrate configured to emit a low level light from the single-use microfluidic cartridge, communicating with a detector device to determine a concentration level of the target chemical from the emitted low level light.
- Other features, examples, and embodiments are described below.
- The accompanying drawings, where like reference numerals refer to identical or functionally similar elements throughout the separate views, together with the detailed description below, are incorporated in and form part of the specification, and serve to further illustrate embodiments of concepts that include the claimed disclosure, and explain various principles and advantages of those embodiments.
- The methods and systems disclosed herein have been represented where appropriate by conventional symbols in the drawings, showing only those specific details that are pertinent to understanding the embodiments of the present disclosure so as not to obscure the disclosure with details that will be readily apparent to those of ordinary skill in the art having the benefit of the description herein.
-
FIG. 1 illustrates an exemplary front view of a portable breath collection and analysis device. -
FIG. 2 illustrates an exemplary back view of a portable breath collection and analysis device. -
FIG. 3 illustrates exemplary air flow from a mouthpiece via a pump system. -
FIG. 4 illustrates a simplified top view of elution and air flow in a cartridge. -
FIG. 5 depicts an exemplary front view of a single-use cartridge. -
FIG. 6 depicts an exemplary back view of a single-use cartridge. -
FIG. 7 is a simplified schematic of a single-use cartridge. -
FIG. 8 illustrates exemplary reaction processes that occur on the single-use cartridge. -
FIG. 9 is an exemplary flow chart of a process conducted within reaction chamber of the single-use cartridge. -
FIG. 10 is an exemplary flow of a process conducted on the single-use cartridge. - In the following description, for purposes of explanation, numerous specific details are set forth in order to provide a thorough understanding of the disclosure. It will be apparent, however, to one skilled in the art, that the disclosure may be practiced without these specific details. In other instances, structures and devices are shown as block diagram form only in order to avoid obscuring the disclosure.
- Reference throughout this specification to βone embodimentβ or βan embodimentβ means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the present invention. Thus, the appearances of the phrases βin one embodimentβ or βin an embodimentβ or βaccording to one embodimentβ (or other phrases having similar import) at various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments. Furthermore, depending on the context of discussion herein, a singular term may include its plural forms and a plural term may include its singular form. Similarly, a hyphenated term (e.g., βon-demandβ) may be occasionally interchangeably used with its non-hyphenated version (e.g., βon demandβ), a capitalized entry (e.g., βDeviceβ) may be interchangeably used with its non-capitalized version (e.g., βdeviceβ), a plural term may be indicated with or without an apostrophe (e.g., PE's or PEs), and an italicized term (e.g., βN+1β) may be interchangeably used with its non-italicized version (e.g., βN+1β). Such occasional interchangeable uses shall not be considered inconsistent with each other.
- The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the singular forms βaβ, βanβ and βtheβ are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms βcomprisesβ and/ or βcomprising,β when used in this specification, specify the presence of stated features, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and/or groups thereof. It is further noted that various figures (including component diagrams) shown and discussed herein are for illustrative purpose only, and are not drawn to scale.
- The present disclosure pertains to methods, systems, and apparatus for capturing human breath at a point of care, extracting certain chemical(s) from the captured breath, and measuring a concentration of the extracted chemicals. In one example, an amount of tetrahydrocannabinol (THC) level from a breath sample is determined by practicing embodiments of the present disclosure. While THC is discussed herein for simplicity, similar methods can be utilized to extract and measure a concentration of other chemicals in human breath as well, such as ethanol, other controlled substances, or airborne indicators of various disease states.
- Embodiments of the present disclosure describe a proprietary microfluidic cartridge that is disposable, and used within a portable breath collection and analysis device. The cartridge is located within a portable handheld device and provides for mechanisms to capture and accurately measure an amount of a target chemical that is present in a person's breath.
- In one example, the target chemical is THC. When THC is present in human breath, the bulk of it is contained within aerosol droplets. The present disclosure relates to mechanisms for capturing those aerosol droplets from human breath, such that a sufficient amount of THC can be captured from a human breath sample to accurately analyze. The THC is extracted from a physical surface of an impaction plate where it is collected and concentrated. The extracted THC is subjected to further analysis, such as to measure a concentration level. In addition to sample processing, the disposable cartridge also allows for processing on-board calibrators, positive controls, and negative controls. In addition, the disposable cartridge may contain a cryptographic computing chip with an RFID tag to attach personal information about the human subject's sample contained and analyzed within the cartridge.
-
FIG. 1 depicts an exemplary front view of a portable breath collection and analysis device 100 (also sometimes referred to herein as simply device 100). In various embodiments, breath collection andanalysis device 100 is a handheld device that can be used at a point of care in any indoor or outdoor location.Device 100 may be utilized in conjunction with a base station (not shown), to accurately determine an amount of a target chemical that is present in a human subject's breath at a given time. - In the exemplary figure of
device 100, there isdisplay 110 that may or may not be a touchscreen. From thisdisplay 110, anadministrator utilizing device 100 to test a subject's breath can view information and results about the breath collection and sampling. As would be understood by persons of ordinary skill in the art, any information can be displayed on thedisplay 110 for the administrator ofdevice 100 and/or a subject whose breath is being tested. - Exemplary
FIG. 1 also depicts alight array 105.Light array 105 may be one or more lights of any kind (such as LED lights), to quickly indicate a status of breath collecting, analysis, or other items. As would be understood by persons of ordinary skill in the art,light array 105 may be located at other places ondevice 100, and not solely in the location depicted inFIG. 1 . -
Device 100 also contains amouthpiece 115, which may be a disposable tube that is placed into a subject's mouth while the subject breathes air intodevice 100. In various embodiments,mouthpiece 115 may be constructed of PVC (polyvinyl chloride) or similar material.Mouthpiece 115 may be further connected todevice 100. In this way,mouthpiece 115 may be a removable and disposable component ofdevice 100. -
FIG. 2 depicts an exemplary back view of breath collection andanalysis device 100. Apower button 125 is depicted in the exemplary figure to turndevice 100 on and off. In various embodiments,power button 125 may be located at other places ondevice 100, rather than solely in the location depicted in exemplaryFIG. 2 . -
FIG. 3 depicts a simplified breath collection mechanism fordevice 100. Amouthpiece 115 is placed into a subject's mouth. Abreath collection module 305 captures air with aerosol droplets potentially containing the target chemical from the subject's breath, until a predetermined volume of air has been captured. Apump 310, that is triggered by apressure sensor 315, may aid in drawing the subject's breath frommouthpiece 115 throughbreath collection module 305. Whenpressure sensor 315 detects that a human subject is blowing air throughmouthpiece 115, it activates (suction) pump 310 to increase the flow rate of air into it and facilitate breath capture. When a subject starts to breathe throughmouthpiece 115,pressure sensor 315 detects a positive pressure atmouthpiece 115 and triggers thepump 310 to turn on. When the subject stops breathing, then pump 310 stops as well. Pump 310 may be connected via a TTL connection to other hardware components withindevice 100. - In an exemplary embodiment, 18 liters of breath is desired to be captured within 2 minutes. For a typical human subject, this is approximately 3-10 breaths. In various embodiments,
device 100 tracks an amount of volume of air collected with each breath of the subject, until the full desired volume is collected. Further, with each breath, pump 310 is activated and then turns off when the breath stops, as detected bypressure sensor 315. That is, if a human subject blows intomouthpiece 115 four times, pump 310 turns on and off with each breath (four times total), within the allotted time (2 minutes in this exemplary embodiment). - Further,
device 100 can track an amount of volume of air collected via a timer. Pump 310 dictates a flow rate of air passing throughbreath collection module 305. Thus, a flow rate of air passing throughbreath collection module 305 is fixed, regardless of how fast or slow a subject blows throughmouthpiece 115. Since the flow rate is dictated bypump 310, and is a known value, an amount of time needed to collect a fixed volume of air (such as 18 liters) can be determined.Device 100 may count down the time for each breath, until the requisite amount of time has elapsed and the desired volume of air is captured. This may help determine depth of sample volume from the subject's respiratory tract to minimize a potential for spoofing the system. - As would be understood by persons of ordinary skill in the art, although 18 liters is discussed herein as the desired volume of air to be captured, the present disclosure is equally applicable to other amounts of desired volume of air capture.
- In various embodiments,
breath collection module 305 may also filter out saliva from the subject's breath. Breath collection module contains a plurality of internal components that are discussed in greater detail in co-pending U.S. patent application Ser. No. NNN filed on DDD. - After breath capture via
breath collection module 305, elution is used to extract the target chemical from the aerosol droplets in the captured breath. In analytical and organic chemistry, elution is the process of extracting one material from another by washing with a solvent. - The captured aerosol droplets are contacted with a fluid to solubilize the target chemical from the aerosol droplets into a solution. By minimizing the volume of solution used to extract the target chemical from the aerosol droplets, the concentration of the target chemical in the solution can be maximized. Further, by utilizing a circular geometry in the
breath collection module 305 pieces, one can minimize the total volume of fluid present in thebreath collection module 305. This enables one to maximize the concentration of the target chemical extracted. - An elution buffer serves to remove the target chemical from an impactor surface in the
breath collection module 305, and is also utilized as a solvent for a reagent in an immunoassay utilized by a cartridge withindevice 100 to analyze the concentration of the target chemical present in the captured sample. Thus, the elution buffer is compatible to an antibody in the immunoassay utilized downstream indevice 100, but also has properties that extract the target chemical from the impactor surface. -
FIG. 4 depicts a top down view of elution and air flow. After air passes through animpactor surface 405 ofbreath collection module 305 and the desired volume of air is captured, the elution fluid passes through theimpactor surface 405 to capture the target chemical. - As depicted in
FIG. 4 , aerosol droplets containing the target chemical are captured from an air flow byimpactor surface 405 inbreath collection module 305, and the remainder of the air is deflected outwards. In some embodiments, a restrictor may be used in thebreath collection module 305 to divert some air (such as up to 5% of air) to a separate path, such as a path to a blood alcohol concentration sensor, thepressure sensor 315, and/or any other sensors. While air flow is being captured, no liquid flow is present. Once the desired volume of air has been captured (e.g., 18 liters), then the air ports may be blocked off via one or more valves, and elution fluid is passed throughimpactor surface 405 to extract the target chemical from the captured aerosol droplets. The elution liquid with the extracted target chemical is then sent downstream to areaction chamber 410 within a cartridge insidedevice 100, for analysis of target chemical concentration. -
FIG. 5 depicts an exemplary front view of a single-use (disposable)cartridge 500 that is utilized withindevice 100 for analysis of the target chemical.Cartridge 500 is connected tomouthpiece 115, andbreath collection module 305, which may also be single-use components fordevice 100.Cartridge 500 contains electronic and chemical components for extraction and analysis of the target chemical in the captured breath sample from the subject. -
FIG. 6 depicts an exemplary back view of single-use cartridge 500. -
FIG. 7 is a simplified schematic of acartridge 500 that is used withindevice 100. As discussed above, breath is captured bybreath collection module 305, facilitated bypump 310. The excess air (after the aerosol droplets have been captured), is released through a vent in thehandheld device 100. Further, while not depicted in the figure, there may be filter(s) or one-way valve(s) present to prevent cross-contamination of samples from one cartridge to the next withindevice 100. - After breath sample capture, an elution fluid with antibody-enzyme conjugate is passed through
breath collection module 305, as discussed above with reference toFIG. 4 . The solubilized target chemical plus the added antibodies are then directed to areaction chamber 710 andevidence sample storage 705. - The
reaction chamber 710 is pre-coated with THC-BSA (Bovine Serum Albumin) conjugate. Withinreaction chamber 710, a process occurs whereby, the sample incubates for a period of time to allow the antibody to competitively bind to target analyte in sample as well as the antigen coated on the surface. Thereaction chamber 710 is then washed to remove any unbound species. Subsequently, a substrate is introduced, which generates a signal proportional to the number of antibody-enzyme molecules bound to the reaction surface. - Turning to
FIG. 8 , thereaction chamber 710 contains three separate and parallel reaction channels: acalibrator channel 805, asample channel 810, and apositive control channel 815. The assay is performed withinreaction chamber 710 such that three separate signals are generatedβone for each reaction channel. The final determination of concentration of target chemical is based on the ratio of the sample signal to the calibrator signal. As would be understood by persons of ordinary skill in the art, there may be fewer or additional reaction chambers than the three discussed herein, in other embodiments. - The fluid entering
reaction chamber 710 has antibody mixed with the target chemical (THC in this example). This fluid enters thesample channel 810. In the calibrator channel, the fluid is just the antibody, which may or may not be mixed with a solution. In thepositive control channel 815, there is a separate reservoir that contains a known amount of the target chemical. Thepositive control channel 815 andcalibrator channel 805 are utilized to ensure that the workflow of the assay in thesample channel 810 processed correctly, and that the reagents ofcartridge 500 are functioning properly. -
Calibrator channel 805 allows for the correction of any small deviations in the response of the chemical reagents present incartridge 500. It can act to compensate for small changes in environmental conditions as well (such as temperature), and/or small changes in the optical train from system to system or cartridge to cartridge. No target chemical is present incalibrator channel 805, and thus it functions as a negative control. - In exemplary embodiments,
reaction chamber 710 provides a competitive immunoassay. That is, the generated signal decreases with an increase in concentration of the target chemical, as depicted ingraph 820. For example, higher signal values indicate a lower concentration of THC, and vice versa. - Thus, since
calibrator channel 805 has no target chemical, it should have a maximum signal value. This provides a baseline for normalization. While there may be some differences in reagent activity from cartridge to the next,calibrator channel 805 provides for the normalization of a signal within each cartridge, since the same reagent is used in all three reaction channels. Thus, the relative response of the reagent in all three channel is harmonized, and a target chemical concentration can be determined based on a relative response between the three reaction channels, rather than an absolute magnitude of a signal generated in any one particular reaction chamber. Thus,calibrator channel 805 creates a relative signal to a maximum signal possible. -
Positive control chamber 815 contains the target chemical (THC), completely isolated from the sample. It is placed in a separate reservoir in thereaction chamber 710. Since the concentration of the target chemical in the positive control sample is known, the expected response of the reagent and the expected signal generated bypositive control chamber 815 is known. By checking the response generated frompositive control chamber 815 against the expected response, it can be objectively determined if the sample processed correctly through thereaction chamber 710. In this way,device 100 can provide a mechanism to verify its own accuracy ofreaction chamber 710. - The negative control from
calibrator channel 805 determines what the generated signal fromreaction chamber 710 would be if there was no THC in the sample. Thepositive control chamber 815 determines what the generated signal from thereaction chamber 710 would be if there was pure THC in the sample. A cutoff point is determined fromgraph 820 for comparison with the generated signal fromsample chamber 810. - In processing a sample,
reaction area 830 ofreaction chamber 710 undergoes a multi-step process. Fluid is introduced intoreaction area 830 via all threereaction channels reaction area 830. It competes with any THC present, whether that THC was introduced from thesample chamber 810 or thepositive control chamber 815. It then binds to an antigen that is on reaction surface 825 and forms a THC-BSA conjugate. - By utilizing this competing immunoassay process, if there are no free THC molecules, all of the antibodies bind to reaction surface 825 and a maximum signal is generated. If there is a high amount of THC, all of the antibodies are tied up with the free THC and there is nothing to bind to reaction surface 825, yielding a low signal.
- After the antibody introduction step,
reaction area 830 is washed by sending a wash buffer solution throughreaction area 830. The wash buffer solution clears away any unbound species fromreaction area 830. In exemplary embodiments, the wash buffer solution may be introduced anywhere from 1-10 times. - After washing, a substrate is introduced into
reaction area 830. In exemplary embodiments, the substrate may be a small molecule such as luminol. Luminol in the presence of an oxidizing agent and an enzyme such as Horseradish Peroxidase (HRP) emits light. - During the reaction process, a catalyst for the reaction may be used within
reaction area 830. In one example, the catalyst is horseradish peroxidate enzyme (HRP). This enzyme catalyzes luminol and produces light. HRP enzyme has a high turnover rate and serves as an effective catalyst for reactions inreaction area 830. - After introduction of the substrate, the amount of light emitted from
reaction chamber 710 is in the order of 0.1-10 pW. - Returning to
FIG. 7 , adetector 715 located in a base station is used to detect the light emitted fromreaction chamber 710. In an exemplary embodiment,detector 715 is a silicon photomultiplier for low light detection. The base station processes the received light signal and determines a concentration of THC that was present in the sample collected from the human subject's breath. - In exemplary embodiments, the
detector 715 may be placed in physical proximity toreaction chamber 715, whencartridge 500 is removed fromdevice 100. In other embodiments,cartridge 500 may have optical fibers with liquid light guides to assist with detection of light being emitted fromreaction chamber 715. This allows for positional flexibility as to where the detector is placed relative tocartridge 500. - While not explicitly depicted in the figures,
cartridge 500 may also have a cryptographic computing chip to store information on the single-use cartridge itself. The cryptographic computing chip ensures thatcartridge 500 can only be utilized with anapproved device 100, base station, and/ordetector 715. Further, cryptographic computing chip may contain a read/write RFID tag to store information about the human subject whose sample is contained withincartridge 500. For example, information regarding the human subject such as any one or more of a unique identifier number, name, age, address, phone number, etc. may be stored on the RFID tag of the cryptographic computing chip oncartridge 500. In addition, objective information such as any one or more of date, time, location, identifier for person administering the test viadevice 100, etc. may also be stored in the cryptographic computing chip. Further, device information and measurement(s) may also be stored on the cryptographic computing chip such as any one or more of breath collection workflow (e.g., breath volume collected, flow rate, number/duration of breaths collected by device 100), assay workflow (e.g., reaction light levels of optical measurements from the reactions), system serial numbers, calibration dates, quantities of the one or more target chemicals, such as a THC level and/or BAC (Blood Alcohol Content) level. - As would be understood by persons of ordinary skill in the art, mechanisms other than an RFID tag may also be used to store information on the cryptographic computing chip. Further, any type of information other than that enumerated here may be stored on the chip.
-
FIG. 7 also depicts anevidence sample storage 705 chamber incartridge 500. Because a sample is usually collected at a point of use away from a testing laboratory, the result fromreaction chamber 710 is written into the cartridge, such as on the cryptographic computing chip ofcartridge 500. However, it is desirable to be able to corroborate this result in a laboratory at a later time using a reference method such as LC-MS. - When testing alcohol on a human subject's breath, there is a known behavior of how the concentration of alcohol in the breath changes over time. Thus, field testing can be used to generate one result, and later verified by testing the subject's breath again with more sophisticated equipment at a law enforcement facility. By measuring the concentration of alcohol in the subject's breath as detected by the more sophisticated equipment, the concentration of alcohol in the subject's breath at a time of a field test can be extrapolated using a known profile for alcohol kinetic behavior over time.
- However, other chemicals, such as THC, do not have similar degradation profiles over time. In particular, THC levels in human breath degrade very quickly in time. Thus, a portion of sample collected from the subject via
device 100 is physically preserved on single-use cartridge 500. In this way, whencartridge 500 is removed fromdevice 100, the sample fromevidence sample storage 705 can be independently tested using reference means (such as mass spectrometry) at a later time to verify a result generated ondevice 100 from a test conducted in a field location. - As shown in
FIG. 7 , after THC is extracted from the sample collected inbreath collection module 305, a small part of the fluid is directed toevidence sample storage 705. In exemplary embodiments, a valving means may be provided to influence the amount of fluid directed toevidence sample storage 705 compared to the amount of fluid directed toreaction chamber 710. -
Evidence sample storage 705 contains a filter with an absorbent material that absorbs the received sample. In a laboratory environment, the absorbent material containing the sample can be removed fromcartridge 500, the contents extracted from the absorbent material into a solvent such as methanol, and then fluid can be processed using known methods such as mass spectrometry. In this way, the absorbent material retains an amount of the original sample before it is processed byreaction chamber 710 ofcartridge 500, and preserves that sample for later testing. - THC is prone to oxidation and degradation of its molecules over time. A key driver of degradation is light exposure. To combat this,
evidence sample storage 705 shields the sample within a compartment ofcartridge 500 such that the sample is opaque on all sides. -
FIG. 9 depicts an exemplary flow chart of a process conducted within the reaction chamber of cartridge 700. It would be understood that there may be fewer or additional steps present than those depicted in the exemplary figure, according to various embodiments of the present disclosure. - In
step 905 of the reaction process, a sample is received by the reaction chamber for analysis of a target chemical. The sample is received from a breath collection module. Instep 910, the received sample is reacted with one or more chemical reagents, as discussed herein. The reacted chemicals are then washed with a wash solution instep 915. A substrate is introduced to the washed and reacted chemicals instep 920. Optionally, a result of the reaction process is generated and saved on a cryptographic computing chip of the cartridge, instep 925. -
FIG. 10 depicts an exemplary flow of a process conducted bycartridge 500 for analysis of a human breath sample received from a human subject. Instep 1005 an air sample is received from a human subject in a breath collection module ofcartridge 500. The received air sample is processed in the breath collection module to solubilize and extract a target chemical instep 1010. The extracted target chemical is combined with an antibody substance instep 1015. A portion of the extracted target chemical is saved for evidence preservation in an evidence sample storage compartment of the cartridge. - A remainder portion of the extracted target chemical is reacted in a reaction chamber with one or more chemical reagents in
step 1025. The reacted chemicals are then washed in the reaction chamber with a wash solution instep 1030. A substrate is introduced to the washed chemicals in the reaction chamber instep 1035. Optionally, a result of the process is generated and saved on a cryptographic computing chip of the cartridge, instep 1040. Further, as discussed herein, a low level light may be generated by the reaction chamber of the cartridge, for detection by a detector device that is separate and apart from the cartridge. - The corresponding structures, materials, acts, and equivalents of all means or step plus function elements in the claims below are intended to include any structure, material, or act for performing the function in combination with other claimed elements as specifically claimed. The description of the present disclosure has been presented for purposes of illustration and description, but is not intended to be exhaustive or limited to the present technology in the form disclosed. Many modifications and variations will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the present disclosure. Exemplary embodiments were chosen and described in order to best explain the principles of the present disclosure and its practical application, and to enable others of ordinary skill in the art to understand the present disclosure for various embodiments with various modifications as are suited to the particular use contemplated.
- Aspects of the present disclosure are described above with reference to flowchart illustrations and/or block diagrams of methods, apparatus (systems) according to embodiments of the present disclosure.
- The flowchart and block diagrams in the Figures illustrate the architecture, functionality, and operation of possible implementations of systems, methods and apparatus, according to various embodiments of the present disclosure.
- Thus, systems and methods for a single-use microfluidic cartridge for detecting a presence of a target chemical in human breath are described herein. While various embodiments have been described, it should be understood that they have been presented by way of example only, and not limitation. The descriptions are not intended to limit the scope of the disclosure to the particular forms set forth herein. Thus, the breadth and scope of a preferred embodiment should not be limited by any of the above-described exemplary embodiments. It should be understood that the above description is illustrative and not restrictive. To the contrary, the present descriptions are intended to cover such alternatives, modifications, and equivalents as may be included within the spirit and scope of the disclosure as defined by the appended claims and otherwise appreciated by one of ordinary skill in the art. The scope of the present disclosure should, therefore, be determined not with reference to the above description, but instead should be determined with reference to the appended claims along with their full scope of equivalents.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/425,938 US20200245898A1 (en) | 2019-01-31 | 2019-05-29 | Single-use Microfluidic Cartridge for Detection of Target Chemical Presence in Human Breath |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962799675P | 2019-01-31 | 2019-01-31 | |
US16/425,938 US20200245898A1 (en) | 2019-01-31 | 2019-05-29 | Single-use Microfluidic Cartridge for Detection of Target Chemical Presence in Human Breath |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200245898A1 true US20200245898A1 (en) | 2020-08-06 |
Family
ID=71836188
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/425,943 Pending US20200245899A1 (en) | 2019-01-31 | 2019-05-29 | Mechanical Breath Collection Device |
US16/425,938 Pending US20200245898A1 (en) | 2019-01-31 | 2019-05-29 | Single-use Microfluidic Cartridge for Detection of Target Chemical Presence in Human Breath |
US16/776,501 Active 2040-12-26 US11821821B1 (en) | 2019-01-31 | 2020-01-29 | Noninvasive point of care biomarker detection from breath samples |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/425,943 Pending US20200245899A1 (en) | 2019-01-31 | 2019-05-29 | Mechanical Breath Collection Device |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/776,501 Active 2040-12-26 US11821821B1 (en) | 2019-01-31 | 2020-01-29 | Noninvasive point of care biomarker detection from breath samples |
Country Status (2)
Country | Link |
---|---|
US (3) | US20200245899A1 (en) |
WO (1) | WO2020159698A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11026596B1 (en) | 2017-05-19 | 2021-06-08 | Hound Labs, Inc. | Detection and measurement of target substance in exhaled breath |
US11187711B1 (en) | 2017-09-11 | 2021-11-30 | Hound Labs, Inc. | Analyte detection from breath samples |
WO2022172222A1 (en) * | 2021-02-12 | 2022-08-18 | 3M Innovative Properties Company | Sample collection device and system |
US11426097B1 (en) | 2018-10-17 | 2022-08-30 | Hound Labs, Inc. | Rotary valve assemblies and methods of use for breath sample cartridge systems |
WO2022208359A1 (en) * | 2021-04-02 | 2022-10-06 | 3M Innovative Properties Company | Sample collection device and method |
WO2022214884A1 (en) * | 2021-04-06 | 2022-10-13 | 3M Innovative Properties Company | Sample collection devices, systems, and methods |
WO2023288079A3 (en) * | 2021-07-16 | 2023-02-16 | Janus-I Science Inc. | Breathalyzer system for detection of respiratory pathogens |
EP4265180A1 (en) * | 2022-04-20 | 2023-10-25 | miDiagnostics NV | Integrated sampling and analysis device |
US11806711B1 (en) | 2021-01-12 | 2023-11-07 | Hound Labs, Inc. | Systems, devices, and methods for fluidic processing of biological or chemical samples using flexible fluidic circuits |
SE2250675A1 (en) * | 2022-06-03 | 2023-12-04 | Munkplast Ab | Method and system for preparing a breath sample for analysis |
US11874286B1 (en) | 2016-05-16 | 2024-01-16 | Hound Labs, Inc. | System and method for target substance identification |
US11933731B1 (en) | 2020-05-13 | 2024-03-19 | Hound Labs, Inc. | Systems and methods using Surface-Enhanced Raman Spectroscopy for detecting tetrahydrocannabinol |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200245899A1 (en) | 2019-01-31 | 2020-08-06 | Hound Labs, Inc. | Mechanical Breath Collection Device |
US11977086B2 (en) | 2019-03-21 | 2024-05-07 | Hound Labs, Inc. | Biomarker detection from breath samples |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030190259A1 (en) * | 2001-10-05 | 2003-10-09 | Alley Kenneth A. | Apparatus for sampling, storing, preserving and testing a specimen |
US20130011859A1 (en) * | 2009-11-23 | 2013-01-10 | Cyvek, Inc. | Method and Apparatus for Performing Assays |
US20140120633A1 (en) * | 2011-09-26 | 2014-05-01 | Carnegie Mellon University | Devices and Methods for Detection and Quantification of Immunological Proteins, Pathogenic and Microbial Agents and Cells |
US20150226726A1 (en) * | 2012-09-11 | 2015-08-13 | Sensa Bues Ab | System and Method for Eluting and Testing Substance From Exhaled Aerosol Sample |
US20160055359A1 (en) * | 2014-08-25 | 2016-02-25 | Covidien Lp | Systems and methods for emulating rfid transponders of a plurality of medical devices |
US20160069919A1 (en) * | 2011-09-25 | 2016-03-10 | Theranos, Inc. | Systems and methods for multi-analysis |
US20190039069A1 (en) * | 2016-01-29 | 2019-02-07 | Purigen Biosystems, Inc. | Isotachophoresis for purification of nucleic acids |
US20190160460A1 (en) * | 2016-06-30 | 2019-05-30 | Lumiradx Uk Ltd. | Fluid control |
Family Cites Families (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3676072A (en) | 1969-09-10 | 1972-07-11 | Portage Research & Dev Corp | Breath test for marijuana smokers and apparatus therefor |
US4133202A (en) * | 1977-04-22 | 1979-01-09 | The Regents Of The University Of Minnesota | Multiple nozzle single stage impactor |
US4771005A (en) | 1983-06-27 | 1988-09-13 | Erez Forensic Technology Ltd. | Reagents, test kits and methods for the detection of cannabinoids |
US4796475A (en) * | 1987-06-25 | 1989-01-10 | Regents Of The University Of Minnesota | Personal air sampling impactor |
US4926679A (en) * | 1987-12-10 | 1990-05-22 | Dewhurst Katharine H | Inertial impaction air sampling device |
US5196306A (en) | 1989-03-29 | 1993-03-23 | E. I. Du Pont De Nemours And Company | Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system |
US5069220A (en) | 1989-05-26 | 1991-12-03 | Bear Medical Systems, Inc. | Measurement of gas concentration in exhaled breath |
US5140993A (en) | 1991-12-27 | 1992-08-25 | Baylor College Of Medicine | Device for collecting a breath sample |
US5361771A (en) | 1993-03-05 | 1994-11-08 | Western Research Company, Inc. | Portable pulmonary function testing device and method |
ATE191560T1 (en) | 1993-07-06 | 2000-04-15 | Aerocrine Ab | SYSTEM FOR DETECTING NO LEVELS IN EXHALED AIR AND DIAGNOSTIC METHOD FOR DEVIATIONS RELATED TO ABNORMAL NO LEVELS |
US6605444B1 (en) | 1993-10-20 | 2003-08-12 | Securetec Detektions-Systems Ag | Method and device for obtaining and detecting immunologically active substances from the gas phase |
US5589346A (en) * | 1994-06-21 | 1996-12-31 | Bioquant, Inc. | Method of monitoring markers of bone metabolism |
US6040191A (en) | 1996-06-13 | 2000-03-21 | Grow; Ann E. | Raman spectroscopic method for determining the ligand binding capacity of biologicals |
US6067983A (en) | 1997-09-19 | 2000-05-30 | Sensormedics Corporation | Method and apparatus for controlled flow sampling from the airway |
US6780617B2 (en) | 2000-12-29 | 2004-08-24 | Chen & Chen, Llc | Sample processing device and method |
AU4957699A (en) | 1998-06-24 | 2000-01-10 | Chen & Chen, Llc | Fluid sample testing system |
US20080050839A1 (en) | 2000-03-21 | 2008-02-28 | Suslick Kenneth S | Apparatus and method for detecting lung cancer using exhaled breath |
US6537823B1 (en) * | 2000-04-24 | 2003-03-25 | Sciteck Diagnostics, Inc. | Method for detection of bromine in urine using liquid chemistry dry chemistry test pads and lateral flow |
US6460539B1 (en) | 2000-09-21 | 2002-10-08 | 3M Innovative Properties Company | Respirator that includes an integral filter element, an exhalation valve, and impactor element |
AU758744B2 (en) | 2000-10-31 | 2003-03-27 | F. Hoffmann-La Roche Ag | Methods for the analysis of non-proteinaceous components using a protease from a bacillus strain |
US20040043479A1 (en) | 2000-12-11 | 2004-03-04 | Briscoe Cynthia G. | Multilayerd microfluidic devices for analyte reactions |
WO2002095359A2 (en) | 2001-05-23 | 2002-11-28 | University Of Florida | Method and apparatus for detecting illicit substances |
US6582376B2 (en) | 2001-09-13 | 2003-06-24 | Pranalytica, Inc. | Alveolar breath collection device and method |
WO2003039483A2 (en) | 2001-11-09 | 2003-05-15 | Dow Global Technologies Inc. | An enzyme-based system and sensor for measuring acetone |
EP1571987A2 (en) | 2002-12-20 | 2005-09-14 | Amidex, Inc. | Breath aerosol collection system and method |
WO2004080597A2 (en) | 2003-02-05 | 2004-09-23 | Iquum, Inc. | Sample processing tubule |
WO2004073497A2 (en) | 2003-02-14 | 2004-09-02 | The Charlotte-Mecklenburg Hospital Authority | Device and method for collection of exhaled alveolar breath condensate |
US7073402B2 (en) * | 2003-08-12 | 2006-07-11 | Skc, Inc. | Air sampler with parallel impactors |
GB0403612D0 (en) | 2004-02-18 | 2004-03-24 | Univ Glasgow | Method, apparatus and kit for breath diagnosis |
WO2006083269A2 (en) | 2004-05-14 | 2006-08-10 | Florida Atlantic University | Luminescent nanosensors |
GB2404023B (en) | 2004-07-02 | 2005-07-06 | Cozart Bioscience Ltd | Delta-9-tetrahydrocannabinol detection method |
US7465586B2 (en) * | 2004-11-03 | 2008-12-16 | Labone, Inc. | Oral detection test for cannabinoid use |
US20060178592A1 (en) | 2005-02-07 | 2006-08-10 | Aperson Biosystems Corp. | System and method for controlling the flow of exhaled breath during analysis |
WO2007002579A2 (en) | 2005-06-23 | 2007-01-04 | Bioveris Corporation | Assay cartridges and methods for point of care instruments |
US20070077660A1 (en) | 2005-09-30 | 2007-04-05 | Glas Ronald J | Method for the detection of a cannabinoid, detection kit, and developing solvent |
US7914460B2 (en) * | 2006-08-15 | 2011-03-29 | University Of Florida Research Foundation, Inc. | Condensate glucose analyzer |
US9586018B2 (en) | 2007-01-26 | 2017-03-07 | Cs Medical, Inc. | System for providing flow-targeted ventilation synchronized to a patients breathing cycle |
CA2701352A1 (en) | 2007-10-02 | 2009-04-09 | Ann-Charlotte Almstrand | Collection and measurement of exhaled particles |
FI20085579A0 (en) | 2008-06-12 | 2008-06-12 | Valtion Teknillinen | Detection of cannabis use |
US8237118B2 (en) | 2008-08-21 | 2012-08-07 | University Of Florida Research Foundation, Inc. | Partial ovoidal FAIMS electrode |
US20110167932A1 (en) * | 2008-09-17 | 2011-07-14 | Research Triangle Institute | Coarse particle exposure monitor |
CA2771830C (en) | 2009-09-09 | 2019-02-26 | Sensa Bues Ab | Drug detection in exhaled breath |
DE102009043236A1 (en) | 2009-09-28 | 2011-04-21 | Siemens Aktiengesellschaft | Multifunction control valve for gas meters |
US9417232B2 (en) | 2009-10-02 | 2016-08-16 | Bi Mobile Breath, Inc. | Sobriety monitoring system |
US8707758B2 (en) | 2009-10-02 | 2014-04-29 | Soberlink, Inc. | Sobriety monitoring system |
WO2012114458A1 (en) * | 2011-02-22 | 2012-08-30 | ζ ͺεΌδΌη€Ύζ₯η«θ£½δ½ζ | Device for capturing microorganisms or like in atmosphere and method for capturing same |
EP2498091A1 (en) | 2011-03-09 | 2012-09-12 | Sensa Bues AB | A vehicle interlocking system and method based on detection of analytes in exhaled breath |
EP2518499B1 (en) | 2011-03-09 | 2015-06-10 | Sensa Bues AB | A portable sampling device and method for drug detection from exhaled breath |
CN103607960A (en) | 2011-07-01 | 2014-02-26 | 3Mεζ°ζιε ¬εΈ | A method and apparatus for screening drug offenders |
WO2013026902A1 (en) * | 2011-08-23 | 2013-02-28 | Aerocrine Ab | Devices and methods for generating an artificial exhalation profile |
US9810704B2 (en) | 2013-02-18 | 2017-11-07 | Theranos, Inc. | Systems and methods for multi-analysis |
US9103766B2 (en) | 2011-10-18 | 2015-08-11 | Breath Diagnostics, Llc | Device and method for monitoring and quantifying analytes |
US20150136604A1 (en) | 2011-10-21 | 2015-05-21 | Integenx Inc. | Sample preparation, processing and analysis systems |
US20140276100A1 (en) * | 2012-02-01 | 2014-09-18 | Invoy Technologies | System for measuring breath analytes |
WO2013117747A1 (en) | 2012-02-08 | 2013-08-15 | Lundin Stefan | A device and method for non-invasive analysis of particles during medical ventilation |
EP3667317A1 (en) * | 2012-03-08 | 2020-06-17 | Sensa Bues AB | A portable sampling device and method for detection of biomarkers in exhaled breath |
US9617582B2 (en) | 2012-09-04 | 2017-04-11 | University Of Maryland College Park | Human exhaled aerosol droplet biomarker system and method |
AU2014212313A1 (en) | 2013-01-30 | 2015-08-20 | Thcer Llc | Articles and methods for rapid THC detection |
EP2762880B1 (en) | 2013-01-31 | 2017-03-15 | Sensirion AG | Portable electronic device with breath analyzer |
WO2014153099A2 (en) | 2013-03-14 | 2014-09-25 | Pulmonary Analytics | Method for using exhaled breath to determine the presence of drug |
EP2781917A1 (en) | 2013-03-18 | 2014-09-24 | Simone Cristoni | Apparatus and method for sampling and analyzing breath |
US9879578B2 (en) * | 2013-03-28 | 2018-01-30 | Cummins Filtration Ip, Inc. | Air-oil separator with jet-enhanced impaction and method associated therewith |
KR20160047565A (en) | 2013-08-30 | 2016-05-02 | μΉ΄νλμ, μΈμ½ν¬λ μ΄ν°λ | Universal breath analysis sampling device |
US20170023546A1 (en) | 2013-12-05 | 2017-01-26 | Theranos, Inc. | Systems, devices, and methods for bodily fluid sample collection, transport, and handling |
US9970950B1 (en) | 2014-03-09 | 2018-05-15 | Hound Labs, Inc. | Method and apparatus for detecting acute use of target substance(s) |
US20150265184A1 (en) | 2014-03-20 | 2015-09-24 | Capnia, Inc. | Selection, segmentation and analysis of exhaled breath for airway disorders assessment |
CA2850998A1 (en) | 2014-04-18 | 2015-10-18 | Thc Breathalyzer, Inc. | Cannabis drug detection device |
US9846125B2 (en) | 2014-09-05 | 2017-12-19 | California Institute Of Technology | Surface enhanced Raman spectroscopy detection of gases, particles and liquids through nanopillar structures |
WO2016065300A1 (en) | 2014-10-24 | 2016-04-28 | Eshoo Mark W | Microfluidic cartridge |
US9726684B1 (en) * | 2015-01-18 | 2017-08-08 | Hound Labs, Inc. | Compositions for target substance detection and measurement |
US20210330516A1 (en) | 2015-10-06 | 2021-10-28 | Undercover Colors, Inc. | Apparatus, system, and method for detecting a target substance |
US10226201B2 (en) | 2015-10-29 | 2019-03-12 | Invoy Holdings, Llc | Flow regulation device for breath analysis and related method |
JP7126445B2 (en) | 2015-11-02 | 2022-08-26 | γγ€γͺγγ‘γ€γ’γ»γγ€γ’γ°γγΉγγ£γ―γΉοΌγͺγγγγγ»γ©γ€γ’γγͺγγ£γ»γ«γ³γγγΌ | Sample preparation for difficult sample types |
WO2017187141A1 (en) * | 2016-04-25 | 2017-11-02 | Owlstone Medical Limited | A method for collecting a selective portion of a subject's breath |
JP6861270B2 (en) | 2016-04-25 | 2021-04-21 | γ’γ¦γ«γΉγγΌγ³γ»γ‘γγ£γ«γ«γ»γͺγγγγοΌ―ο½ο½ο½ο½ο½ο½ο½ οΌο½ ο½ο½ο½ο½ο½ οΌ¬ο½ο½ο½ο½ο½ ο½ | Systems and devices for capturing exhaled breath samples |
US9933445B1 (en) | 2016-05-16 | 2018-04-03 | Hound Labs, Inc. | System and method for target substance identification |
US9921234B1 (en) | 2016-06-17 | 2018-03-20 | Hound Labs, Inc. | Compositions and methods for detection of target constituent in exhaled breath |
CN106290300A (en) | 2016-08-04 | 2017-01-04 | εζΉε¨θ§ζζ―θ‘δ»½ζιε ¬εΈ | Portable raman spectrometer |
US20200046253A1 (en) | 2016-10-28 | 2020-02-13 | Cannabix Technologies Inc. | Intercept system for controlled substances |
GB2561239B (en) | 2017-04-07 | 2021-09-15 | Owlstone Med Ltd | Improved breath sampling device and method |
GB201707999D0 (en) | 2017-05-18 | 2017-07-05 | Owlstone Med Ltd | Multiple breath sampling method |
US11026596B1 (en) | 2017-05-19 | 2021-06-08 | Hound Labs, Inc. | Detection and measurement of target substance in exhaled breath |
SE541748C2 (en) | 2017-07-10 | 2019-12-10 | Pexa Ab | System for collecting exhaled particles |
US11187711B1 (en) | 2017-09-11 | 2021-11-30 | Hound Labs, Inc. | Analyte detection from breath samples |
GB2566453B (en) | 2017-09-12 | 2021-01-13 | Univ Of Northumbria At Newcastle | Impactor for aerosol component collection |
US20200124625A1 (en) | 2018-10-19 | 2020-04-23 | SannTek Labs Inc. | Systems and methods for detecting a target analyte in a breath sample |
US20200245899A1 (en) | 2019-01-31 | 2020-08-06 | Hound Labs, Inc. | Mechanical Breath Collection Device |
US11723553B2 (en) | 2019-02-11 | 2023-08-15 | Giner, Inc. | Method and system for detection and/or quantification of delta-9-tetrahydrocannabinol in exhaled breath |
US11977086B2 (en) * | 2019-03-21 | 2024-05-07 | Hound Labs, Inc. | Biomarker detection from breath samples |
-
2019
- 2019-05-29 US US16/425,943 patent/US20200245899A1/en active Pending
- 2019-05-29 US US16/425,938 patent/US20200245898A1/en active Pending
-
2020
- 2020-01-14 WO PCT/US2020/013553 patent/WO2020159698A1/en active Application Filing
- 2020-01-29 US US16/776,501 patent/US11821821B1/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030190259A1 (en) * | 2001-10-05 | 2003-10-09 | Alley Kenneth A. | Apparatus for sampling, storing, preserving and testing a specimen |
US20130011859A1 (en) * | 2009-11-23 | 2013-01-10 | Cyvek, Inc. | Method and Apparatus for Performing Assays |
US20160069919A1 (en) * | 2011-09-25 | 2016-03-10 | Theranos, Inc. | Systems and methods for multi-analysis |
US20140120633A1 (en) * | 2011-09-26 | 2014-05-01 | Carnegie Mellon University | Devices and Methods for Detection and Quantification of Immunological Proteins, Pathogenic and Microbial Agents and Cells |
US20150226726A1 (en) * | 2012-09-11 | 2015-08-13 | Sensa Bues Ab | System and Method for Eluting and Testing Substance From Exhaled Aerosol Sample |
US20160055359A1 (en) * | 2014-08-25 | 2016-02-25 | Covidien Lp | Systems and methods for emulating rfid transponders of a plurality of medical devices |
US20190039069A1 (en) * | 2016-01-29 | 2019-02-07 | Purigen Biosystems, Inc. | Isotachophoresis for purification of nucleic acids |
US20190160460A1 (en) * | 2016-06-30 | 2019-05-30 | Lumiradx Uk Ltd. | Fluid control |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11874286B1 (en) | 2016-05-16 | 2024-01-16 | Hound Labs, Inc. | System and method for target substance identification |
US11026596B1 (en) | 2017-05-19 | 2021-06-08 | Hound Labs, Inc. | Detection and measurement of target substance in exhaled breath |
US11187711B1 (en) | 2017-09-11 | 2021-11-30 | Hound Labs, Inc. | Analyte detection from breath samples |
US11426097B1 (en) | 2018-10-17 | 2022-08-30 | Hound Labs, Inc. | Rotary valve assemblies and methods of use for breath sample cartridge systems |
US11933731B1 (en) | 2020-05-13 | 2024-03-19 | Hound Labs, Inc. | Systems and methods using Surface-Enhanced Raman Spectroscopy for detecting tetrahydrocannabinol |
US11806711B1 (en) | 2021-01-12 | 2023-11-07 | Hound Labs, Inc. | Systems, devices, and methods for fluidic processing of biological or chemical samples using flexible fluidic circuits |
WO2022172222A1 (en) * | 2021-02-12 | 2022-08-18 | 3M Innovative Properties Company | Sample collection device and system |
WO2022208359A1 (en) * | 2021-04-02 | 2022-10-06 | 3M Innovative Properties Company | Sample collection device and method |
WO2022214884A1 (en) * | 2021-04-06 | 2022-10-13 | 3M Innovative Properties Company | Sample collection devices, systems, and methods |
WO2023288079A3 (en) * | 2021-07-16 | 2023-02-16 | Janus-I Science Inc. | Breathalyzer system for detection of respiratory pathogens |
EP4265180A1 (en) * | 2022-04-20 | 2023-10-25 | miDiagnostics NV | Integrated sampling and analysis device |
SE2250675A1 (en) * | 2022-06-03 | 2023-12-04 | Munkplast Ab | Method and system for preparing a breath sample for analysis |
Also Published As
Publication number | Publication date |
---|---|
US20200245899A1 (en) | 2020-08-06 |
WO2020159698A1 (en) | 2020-08-06 |
US11821821B1 (en) | 2023-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200245898A1 (en) | Single-use Microfluidic Cartridge for Detection of Target Chemical Presence in Human Breath | |
US11977086B2 (en) | Biomarker detection from breath samples | |
US9816980B2 (en) | Apparatus and corresponding method for sampling and analyzing drugs and respective metabolites in breath air, particularly suitable for performing road drug tests | |
US20130006068A1 (en) | Method and apparatus for screening drug offenders | |
US11709170B2 (en) | Device and method for detecting multiple target substances of abuse | |
CN104471382B (en) | Hot comparative determination and reader | |
Xue et al. | Rapid and sensitive detection of drugs of abuse in sweat by multiplexed capillary based immuno-biosensors | |
JP2004537038A (en) | Biological measurement system | |
US9824870B1 (en) | Portable medical diagnosis instrument | |
US8481330B2 (en) | Method for analyzing sample solution and apparatus for analyzing sample solution | |
GB2378753A (en) | Collection and analysis of entrained components | |
CN101278195A (en) | Apparatus assembly and method for detecting an analyte | |
US9851348B2 (en) | System and method for lateral flow immunoassay testing | |
AU2021258739A1 (en) | Digital microfluidic device, system and method for performing a plasmonic particle-assisted elisa self-test | |
TWM502845U (en) | Reagent cartridge slot structure | |
US20030129673A1 (en) | Test apparatus for the detection of pharmacologically active compounds from saliva | |
CN108348196A (en) | Without reagent test strip system and method | |
CN115032185A (en) | Nucleic acid rapid detection device based on CRISPR technology | |
US20190195842A1 (en) | Testing apparatus and control method thereof | |
EP4220165A1 (en) | Method and device for the detection of traumatic brain injuries | |
Straume et al. | Portable Medical Diagnosis Instrument | |
Xiong-Hang et al. | Development of a rapid assay for on-site THC detection in oral fluid | |
Gug et al. | Salivary Biomarkers in Toxicology: An Update Narrative | |
Kim et al. | Evaluation of a lateral flow assay for rapid and simple detection of IFN-Ξ³ for the diagnosis of Mycobacterium tuberculosis infection | |
Stefanuto et al. | Breath Volatolomics for Medical Applications. Are We There Yet? |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: HOUND LABS, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HEANUE, JOSEPH A.;STOLL, JEFFREY A.;ANEKAL, SAMARTHA G.;AND OTHERS;SIGNING DATES FROM 20190515 TO 20190520;REEL/FRAME:049478/0461 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION COUNTED, NOT YET MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |